385 related articles for article (PubMed ID: 19402070)
1. Magnetic resonance imaging as a biomarker in renal cell carcinoma.
Pedrosa I; Alsop DC; Rofsky NM
Cancer; 2009 May; 115(10 Suppl):2334-45. PubMed ID: 19402070
[TBL] [Abstract][Full Text] [Related]
2. Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).
De Bazelaire C; Rofsky NM; Duhamel G; Michaelson MD; George D; Alsop DC
Acad Radiol; 2005 Mar; 12(3):347-57. PubMed ID: 15766695
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma.
de Bazelaire C; Alsop DC; George D; Pedrosa I; Wang Y; Michaelson MD; Rofsky NM
Clin Cancer Res; 2008 Sep; 14(17):5548-54. PubMed ID: 18765547
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
Rosen MA; Schnall MD
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
[TBL] [Abstract][Full Text] [Related]
5. [MR imaging features of different renal cell carcinoma subtypes].
Wu B; Peng WJ; Gu YJ; Yang TX; Jiang ZX; Zhang HL; Dai B; Ye DW; Kong YY; Du X
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):825-30. PubMed ID: 19173827
[TBL] [Abstract][Full Text] [Related]
6. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
[TBL] [Abstract][Full Text] [Related]
7. Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study.
Notohamiprodjo M; Sourbron S; Staehler M; Michaely HJ; Attenberger UI; Schmidt GP; Boehm H; Horng A; Glaser C; Stief C; Reiser MF; Herrmann KA
J Magn Reson Imaging; 2010 Feb; 31(2):490-501. PubMed ID: 20099364
[TBL] [Abstract][Full Text] [Related]
8. MR imaging of renal cell carcinoma: its role in determining cell type.
Yoshimitsu K; Irie H; Tajima T; Nishie A; Asayama Y; Hirakawa M; Nakayama T; Kakihara D; Honda H
Radiat Med; 2004; 22(6):371-6. PubMed ID: 15648450
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
[TBL] [Abstract][Full Text] [Related]
10. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
Choi YA; Kim CK; Park SY; Cho SW; Park BK
AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation.
Chandarana H; Kang SK; Wong S; Rusinek H; Zhang JL; Arizono S; Huang WC; Melamed J; Babb JS; Suan EF; Lee VS; Sigmund EE
Invest Radiol; 2012 Dec; 47(12):688-96. PubMed ID: 22996315
[TBL] [Abstract][Full Text] [Related]
12. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
[TBL] [Abstract][Full Text] [Related]
13. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
14. Tumor perfusion assessed by dynamic contrast-enhanced MRI correlates to the grading of renal cell carcinoma: initial results.
Palmowski M; Schifferdecker I; Zwick S; Macher-Goeppinger S; Laue H; Haferkamp A; Kauczor HU; Kiessling F; Hallscheidt P
Eur J Radiol; 2010 Jun; 74(3):e176-80. PubMed ID: 19540690
[TBL] [Abstract][Full Text] [Related]
15. Diffusion and perfusion of the kidney.
Notohamiprodjo M; Reiser MF; Sourbron SP
Eur J Radiol; 2010 Dec; 76(3):337-47. PubMed ID: 20580179
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma in patients with acquired cystic disease of the kidney: assessment using a combination of T2-weighted, diffusion-weighted, and chemical-shift MRI without the use of contrast material.
Akita H; Jinzaki M; Akita A; Mikami S; Oya M; Kuribayashi S
J Magn Reson Imaging; 2014 Apr; 39(4):924-30. PubMed ID: 24123320
[TBL] [Abstract][Full Text] [Related]
17. Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging.
Kim JH; Bae JH; Lee KW; Kim ME; Park SJ; Park JY
Urology; 2012 Oct; 80(4):872-6. PubMed ID: 22854134
[TBL] [Abstract][Full Text] [Related]
18. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
[TBL] [Abstract][Full Text] [Related]
19. The vascular architecture of renal cell carcinoma in fine-needle aspiration biopsies. An aid in its distinction from hepatocellular carcinoma.
Weir M; Pitman MB
Cancer; 1997 Feb; 81(1):45-50. PubMed ID: 9100541
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
